Cargando…
Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects
Endometriosis is a chronic pain condition affecting 1 in 10 women. There is an unmet need for better medical treatments for endometriosis. We spotlight trials of a single preparation combined HRT-GnRH antagonist (Relugolix) by Giudice et al.,(1) for endometriosis-associated pain.
Autores principales: | Whitaker, L.H.R., Saraswat, L., Horne, A.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512692/ https://www.ncbi.nlm.nih.gov/pubmed/36130483 http://dx.doi.org/10.1016/j.xcrm.2022.100748 |
Ejemplares similares
-
Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015) -
Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023) -
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012) -
GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors
por: Sperduti, Samantha, et al.
Publicado: (2019) -
Comparing ART outcomes in women with endometriosis after GnRH agonist
versus GnRH antagonist ovarian stimulation: a systematic
review
por: Kuan, Kevin K.W., et al.
Publicado: (2023)